Mesothelioma and the tumour suppressor gene, NF2

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Update on the METABRIC consortium 2000 Breast Cancer Study

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence

Implementation of individualised treatment and the WINTHER trial

Importance of personalised medicine and the WIN Consortium

The role of physicians and researchers in the medical community

Achievements of the WIN Consortium

Interview with Nobel Prize winner Sir Tim Hunt

Report from the Asian Myeloma Network